2006 Ohio Revised Code - 3719.41. Schedules.

§ 3719.41. Schedules.
 

Publisher's Note: The following is a compilation of substances scheduled pursuant to RC §§ 3719.41 (07/01/76, 05/19/93, 07/21/94, 07/01/96, 05/17/00), 3719.43, and 3719.44. This compilation has been prepared by the Ohio State Board of Pharmacy to assist health professionals and law enforcement officers in determining: (1) whether or not a drug or drug product is a controlled substance; (2) which schedule a substance has been placed in; (3) whether or not the substance was placed in, added to, or transferred to a different schedule according to Section 3719.41, 3719.43, and/or 3719.44 of the Revised Code; and (4) the date that each substance was added to or transferred from one schedule to another. Following each substance, in parenthesis or brackets, are the dates that the substance was placed in that schedule. The date in parentheses ( ) indicates the date that a substance was placed in the schedule by the federal government. A date prior to July 1, 1976, the original enactment date of RC § 3719.41, indicates the date that the substance was controlled under federal law only (i.e. Comprehensive Drug Abuse Prevention and Control Act of 1970; 21 U.S.C. 801-966). The date in brackets [ ] indicates the date that the substance was added or transferred to the schedule by the Board pursuant to § 3719.44. Footnotes are used to provide additional information. 
 

The following is a compilation of substances scheduled pursuant to RC §§ 3719.41, 3719.43, and 3719.44. 
   
SCHEDULE I 

(A) Narcotics-opiates 

Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted under federal drug abuse control laws, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation: 

(1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide); (11-29-85) 

(2) Acetylmethadol; (5-1-71) 

(3) Allylprodine; (5-1-71) 

(4) Alphacetylmethadol (except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM); (5-1-71) (8-18-93)1 

(5) Alphameprodine; (5-1-71) 

(6) Alphamethadol; (5-1-71) 

(7) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine); (9-22-81) 

(8) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide); (11-29-85) 

(9) Benzethidine; (5-1-71) 

(10) Betacetylmethadol; (5-1-71) 

(11) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl-4-piperidinyl]-N-phenylpropanamide); (11-29-85) 

(12) Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide); (1-08-88) 

(13) Betameprodine; (5-1-71) 

(14) Betamethadol; (5-1-71) 

(15) Betaprodine; (5-1-71) 

(16) Clonitazene; (5-1-71) 

(17) Dextromoramide; (5-1-71) 

(18) Diampromide; (5-1-71) 

(19) Diethylthiambutene; (5-1-71) 

(20) Difenoxin; (6-1-75) [4-1-78] 

(21) Dimenoxadol; (5-1-71) 

(22) Dimepheptanol; (5-1-71) 

(23) Dimethylthiambutene; (5-1-71) 

(24) Dioxaphetyl butyrate; (5-1-71) 

(25) Dipipanone; (5-1-71) 

(26) Ethylmethylthiambutene; (5-1-71) 

(27) Etonitazene; (5-1-71) 

(28) Etoxeridine; (5-1-71) 

(29) Furethidine; (5-1-71) 

(30) Hydroxypethidine; (5-1-71) 

(31) Ketobemidone; (5-1-71) 

(32) Levomoramide; (5-1-71) 

(33) Levophenacylmorphan; (5-1-71) 

(34) 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide); (4-25-85) 

(35) 3-methylthiofentanyl (N-[3-methyl-1-[2-(thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide); (11-29-85) 

(36) Morpheridine; (5-1-71) 

(37) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine); (8-12-85) 

(38) Noracymethadol; (5-1-71) 

(39) Norlevorphanol; (5-1-71) 

(40) Normethadone; (5-1-71) 

(41) Norpipanone; (5-1-71) 

(42) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl]propanamide; (3-10-86) 

(43) PEPAP (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine; (8-12-85) 

(44) Phenadoxone; (5-1-71) 

(45) Phenampromide; (5-1-71) 

(46) Phenomorphan; (5-1-71) 

(47) Phenoperidine; (5-1-71) 

(48) Piritramide; (5-1-71) 

(49) Proheptazine; (5-1-71) 

(50) Properidine; (5-1-71) 

(51) Propiram; (2-28-72) 

(52) Racemoramide; (5-1-71) 

(53) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide; (11-29-85) 

(54) Tilidine; (12-1-80) 

(55) Trimeperidine. (5-1-71) 

(B) Narcotics-opium derivatives 

Any of the following opium derivatives, including their salts, isomers, and salts of isomers, unless specifically excepted under federal drug abuse control laws, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: 

(1) Acetorphine; (5-1-71) 

(2) Acetyldihydrocodeine; (5-1-71) 

(3) Benzylmorphine; (5-1-71) 

(4) Codeine methylbromide; (5-1-71) 

(5) Codeine-n-oxide; (5-1-71) 

(6) Cyprenorphine; (5-1-71) 

(7) Desomorphine; (5-1-71) 

(8) Dihydromorphine; (5-1-71) 

(9) Drotebanol; (8-6-73) 

(10) Etorphine (except hydrochloride salt); (5-1-71) 

(11) Heroin; (5-1-71) 

(12) Hydromorphinol; (5-1-71) 

(13) Methyldesorphine; (5-1-71) 

(14) Methyldihydromorphine; (5-1-71) 

(15) Morphine methylbromide; (5-1-71) 

(16) Morphine methylsulfonate; (5-1-71) 

(17) Morphine-n-oxide; (5-1-71) 

(18) Myrophine; (5-1-71) 

(19) Nicocodeine; (5-1-71) 

(20) Nicomorphine; (5-1-71) 

(21) Normorphine; (5-1-71) 

(22) Pholcodine; (5-1-71) 

(23) Thebacon. (5-1-71) 

(C) Hallucinogens 

Any material, compound, mixture, or preparation that contains any quantity of the following hallucinogenic substances, including their salts, isomers, and salts of isomers, unless specifically excepted under federal drug abuse control laws, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation. For the purposes of this division only, "isomer" includes the optical isomers, position isomers, and geometric isomers. 

(1) Alpha-ethyltryptamine (some trade or other names: etryptamine; Monase; alpha-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; alpha-ET; and AET); (9-12-94)2 

(2) 4-bromo-2,5-dimethoxyamphetamine (some trade or other names: 4-bromo-2,5-dimethoxy-alpha-methyphenethylamine; 4-bromo-2,5-DMA); (9-21-73) 

(3) 4-bromo-2,5-dimethoxyphenethylamine (some trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus); (6-2-95)3 

(4) 2,5-dimethoxyamphetamine (some trade or other names: 2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA); (9-21-73) 

(5) 2,5-dimethoxy-4-ethylamphetamine (some trade or other names: DOET); (2-16-93) 

(6) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7); (3-18-04)4 

(7) 4-methoxyamphetamine (some trade or other names: 4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine; PMA); (9-21-73) 

(8) 5-methoxy-3,4-methylenedioxy-amphetamine; (5-1-71) 

(9) 4-methyl-2,5-dimethoxy-amphetamine (some trade or other names: 4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; "DOM" and "STP"); (5-1-71) 

(10) 3,4-methylenedioxy amphetamine; (5-1-71) 

(11) 3,4-methylenedioxymethamphetamine (MDMA); (7-1-85) 

(12) 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA); (10-15-87) 

(13) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine and N-hydroxy MDA); (10-15-87) 

(14) 3,4,5-trimethoxy amphetamine; (5-1-71) 

(15) Alpha-methyltryptamine (other name: AMT); (9-29-04)5 

(16) Bufotenine (some trade or other names: 3-(beta-dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N, N-dimethyltryptamine; mappine); (5-1-71) 

(17) Diethyltryptamine (some trade or other names: N, N-diethyltryptamine; DET); (5-1-71) 

(18) Dimethyltryptamine (some trade or other names: DMT); (5-1-71) 

(19) 5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT); (9-29-04)5 

(20) Ibogaine (some trade or other names: 7-ethyl-6,6 beta,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido[1',2':1,2] azepino [5, 4-b] indole; tabernanthe iboga); (5-1-71) 

(21) Lysergic acid diethylamide; (5-1-71) 

(22) Marihuana; (5-1-71) 

(23) Mescaline; (5-1-71) 

(24) Parahexyl (some trade or other names: 3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; synhexyl); (12-22-82) 

(25) Peyote (meaning all parts of the plant presently classified botanically as "Lophophora williamsii Lemaire," whether growing or not, the seeds of that plant, any extract from any part of that plant, and every compound, manufacture, salts, derivative, mixture, or preparation of that plant, its seeds, or its extracts); (5-1-71) (1-21-76) (10-1-76) 

(26) N-ethyl-3-piperidyl benzilate; (5-1-71) 

(27) N-methyl-3-piperidyl benzilate; (5-1-71) 

(28) Psilocybin; (5-1-71) 

(29) Psilocyn; (5-1-71) 

(30) Tetrahydrocannabinols [Meaning tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances conrtainedÅ in the plant, such as the following: 1 cis or trans tetrahydrocannabinol, and their optical isomers; 6 cis or trans tetrahydrocannabinol, and their optical isomers; 3, 4 cis or trans tetrahydrocannabinol, and its optical isomers. (Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered.)]; (4-21-03) 

(31) Ethylamine analog of phencyclidine (some trade or other names: N-ethyl-1-phenylcyclohexylamine; (1-phenyl-cyclohexyl)ethylamine; N-(1-phenylcyclohexyl)ethylamine; cyclohexamine; PCE); (10-25-78)6 

(32) Pyrrolidine analog of phencyclidine (some trade or other names: 1-(1-phenylcyclohexyl)pyrrolidine; PCPy; PHP); (10-25-78)6 

(33) Thiophene analog of phencyclidine (some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine; 2-thienyl analog of phencyclidine; TPCP; TCP); (8-11-75) [4-1-78] 

(34) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine; (7-6-89) 

(35) Hashish.  

(D) Depressants 

Any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including their salts, isomers, and salts of isomers, unless specifically excepted under federal drug abuse control laws, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: 

(1) Gamma-hydroxybutyric acid (some other names include GHB; gammahydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate); (3-13-00)7 

(2) Mecloqualone; (7-10-75) [4-1-78] 

(3) Methaqualone. (8-27-84)8 

(E) Stimulants 

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, isomers, and salts of isomers: 

(1) Aminorex (some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenyl-2-oxazolamine); (3-18-94)9 

(2) N-benzylpiperazine (some other names: BZP, 1-benzylpiperazine); (3-18-04)1

(3) Cathinone (some trade or other names: 2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone); (2-16-93) 

(4) Fenethylline; (8-20-81) 

(5) Methcathinone (some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR1432), its salts, optical isomers, and salts of optical isomers; (10-15-93)1

(6) (+/-)cis-4-methylaminorex ((+/-)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine); (10-15-87) 

(7) N-ethylamphetamine; (1-7-82) 

(8) N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine). (8-3-88) 

(F) Temporary Listing Of Substances Subject To Emergency Scheduling1

Any material, compound, mixture or preparation which contains any quantity of the following substances: 

(1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical isomers, salts and salts of isomers; (11-29-85)1

(2) N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl), its optical isomers, salts and salts of isomers. (11-29-85)1

(3) 1-(3-trifluoromethylphenyl)piperazine (other name: TFMPP), its opticalisomers, salts and salts of isomers. (9-20-02, 9-10-03)1
   
SCHEDULE II 

(A) Narcotics-opium and opium derivatives 

Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin, independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis: 

(1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, excluding apomorphine (6-28-76) [4-1-78], thebaine-derived butorphanol (7-14-92), dextrorphan (10-1-76), nalbuphine (10-1-76) [4-1-78], nalmefene (11-4-85), naloxone, and naltrexone (3-6-75) [4-1-78], and their respective salts, but including the following: 

(a) Raw opium; (5-1-71) 

(b) Opium extracts; (5-1-71) 

(c) Opium fluid extracts; (5-1-71) 

(d) Powdered opium; (5-1-71) 

(e) Granulated opium; (5-1-71) 

(f) Tincture of opium; (5-1-71) 

(g) Codeine; (5-1-71) 

(h) Dihydroetorphine; (11-17-00) 

(i) Ethylmorphine; (5-1-71) 

(j) Etorphine hydrochloride; (4-18-74) 

(k) Hydrocodone; (5-1-71) 

(l) Hydromorphone; (5-1-71) 

(m) Metopon; (5-1-71) 

(n) Morphine; (5-1-71) 

(o) Oxycodone; (5-1-71) 

(p) Oxymorphone; (5-1-71) 

(q) Thebaine. (5-1-71) 

(2) Any salt, compound, derivative, or preparation thereof that is chemically equivalent to or identical with any of the substances referred to in division (A)(1) of this schedule, except that these substances shall not include the isoquinoline alkaloids of opium; (5-1-71) 

(3) Opium poppy and poppy straw; (5-1-71) 

(4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves (including cocaine and ecgonine, their salts, isomers, and derivatives, and salts of those isomers and derivatives), and any salt, compound, derivative, or preparation thereof that is chemically equivalent to or identical with any of these substances, except that the substances shall not include decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine; (5-1-71) (4-23-86) 

(5) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid, or powder form that contains the phenanthrene alkaloids of the opium poppy). (2-14-75) 

(B) Narcotics-opiates 

Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation, but excluding dextrorphan and levopropoxyphene: (9-22-80) 

(1) Alfentanil; (1-23-87)1

(2) Alphaprodine; (5-1-71) 

(3) Anileridine; (5-1-71) 

(4) Bezitramide; (5-1-71) 

(5) Bulk dextropropoxyphene (non-dosage forms); (9-22-80)1

(6) Carfentanil; (10-28-88) 

(7) Dihydrocodeine; (5-1-71) 

(8) Diphenoxylate; (5-1-71) 

(9) Fentanyl; (5-1-71) 

(10) Isomethadone; (5-1-71) 

(11) Levo-alphacetylmethadol (some other names: levo-alpha-acetylmethadol; levomethadyl acetate; LAAM); (8-18-93)1

(12) Levomethorphan; (5-1-71) 

(13) Levorphanol; (5-1-71) 

(14) Metazocine; (5-1-71) 

(15) Methadone; (5-1-71) 

(16) Methadone-intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane; (5-1-71) 

(17) Moramide-intermediate, 2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid; (5-1-71) 

(18) Pethidine (meperidine); (5-1-71) 

(19) Pethidine-intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine; (5-1-71) 

(20) Pethidine-intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate; (5-1-71) 

(21) Pethidine-intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid; (5-1-71) 

(22) Phenazocine; (5-1-71) 

(23) Piminodine; (5-1-71) 

(24) Racemethorphan; (5-1-71) 

(25) Racemorphan; (5-1-71) 

(26) Remifentanil; (11-5-96) 

(27) Sufentanil. (5-25-84)1

(C) Stimulants 

Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system: (7-7-71) 

(1) Amphetamine, its salts, its optical isomers, and salts of its optical isomers; (7-7-71) 

(2) Methamphetamine, its salts, its isomers, and salts of its isomers; (7-7-71) 

(3) Methylphenidate; (10-28-71) 

(4) Phenmetrazine and its salts. (10-28-71) 

(D) Depressants 

Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including their salts, isomers, and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: 

(1) Amobarbital; (12-17-73) 

(2) Glutethimide; (3-21-91)1

(3) Pentobarbital; (12-17-73) 

(4) Phencyclidine (some trade or other names: 1-(1-phenylcyclohexyl)piperidine; PCP); (2-24-78) [7-1-78] 

(5) Secobarbital; (12-17-73) 

(6) 1-aminophenylcyclohexane and all N-mono-substituted and/or all N-N-disubstituted analogs including, but not limited to, the following:2

(a) 1-phenylcyclohexylamine; [7-1-78] 

(b) (1-phenylcyclohexyl) methylamine; [7-1-78] 

(c) (1-phenylcyclohexyl) dimethylamine; [7-1-78] 

(d) (1-phenylcyclohexyl) methylethylamine; [7-1-78] 

(e) (1-phenylcyclohexyl) isopropylamine; [7-1-78] 

(f) 1-(1-phenylcyclohexyl) morpholine. [7-1-78] 

(E) Hallucinogenic substances2

(1) Nabilone (another name for nabilone: (+)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one). (4-7-87) 

(F) Immediate precursors 

Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances: 

(1) Immediate precursor to amphetamine and methamphetamine: 

(a) Phenylacetone (some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone); (2-11-80) 

(2) Immediate precursors to phencyclidine (PCP): 

(a) 1-phenylcyclohexylamine; (6-16-78) 

(b) 1-piperidinocyclohexanecarbonitrile (PCC). (6-16-78) 
   
SCHEDULE III 

(A) Stimulants 

Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, their optical isomers, position isomers, or geometric isomers, and salts of these isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: 

(1) All stimulant compounds, mixtures, and preparations included in schedule III pursuant to the federal drug abuse control laws and regulations adopted under those laws; (6-15-73) 

(2) Benzphetamine; (6-15-73) 

(3) Chlorphentermine; (6-15-73) 

(4) Clortermine; (6-15-73) 

(5) Phendimetrazine. (6-15-73) 

(B) Depressants 

Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system: (11-8-73) 

(1) Any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs, and one or more other active medicinal ingredients that are not listed in any schedule; (11-8-73) 

(2) Any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs and approved by the food and drug administration for marketing only as a suppository; (11-8-73) 

(3) Any substance that contains any quantity of a derivative of barbituric acid or any salt of a derivative of barbituric acid; (5-1-71) 

(4) Chlorhexadol; (5-1-71) 

(5) Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act; (3-13-00)2

(6) Ketamine, its salts, isomers, and salts of isomers (some other names for ketamine: (+/-)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone); (8-12-99) 

(7) Lysergic acid; (5-1-71) 

(8) Lysergic acid amide; (5-1-71) 

(9) Methyprylon; (5-1-71) 

(10) Sulfondiethylmethane; (5-1-71) 

(11) Sulfonethylmethane; (5-1-71) 

(12) Sulfonmethane; (5-1-71) 

(13) Tiletamine, zolazepam, or any salt of tiletamine or zolazepam (some trade or other names for a tiletamine-zolazepam combination product: Telazol); (some trade or other names for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone); (some trade or other names for zolazepam: 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e][1,4]-diazepin-7(1H)-one; flypyrazapon). (2-20-87) 

(C) Narcotic antidotes 

(1) Nalorphine. (5-1-71) 

(D) Narcotics-narcotic preparations 

Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule: 

(1) Any material, compound, mixture, or preparation that contains any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below: (7-26-79) 

(a) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium; (5-1-71) 

(b) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (5-1-71) 

(c) Not more than 300 milligrams of dihydrocodeinone (hydrocodone) per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium; (5-1-71) 

(d) Not more than 300 milligrams of dihydrocodeinone (hydrocodone) per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (5-1-71) 

(e) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (5-1-71) 

(f) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (5-1-71) 

(g) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (5-1-71) 

(h) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts. (5-1-71) 

(2) Any material, compound, mixture, or preparation containing any of the following narcotic drugs or their salts, as set forth below: 

(a) Buprenorphine. (10-07-02)2

(E) Anabolic steroids 

Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances, including their salts, esters, isomers, and salts of esters and isomers, whenever the existence of these salts, esters, and isomers is possible within the specific chemical designation: 

(1) Anabolic steroids. (2-27-91)24 Except as otherwise provided in division (E)(1) of schedule III, "anabolic steroids" means any drug or hormonal substance that is chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) and that promotes muscle growth. "Anabolic steroids" does not include an anabolic steroid that is expressly intended for administration through implants to cattle or other nonhuman species and that has been approved by the United States secretary of health and human services for that administration, unless a person prescribes, dispenses, or distributes this type of anabolic steroid for human use. "Anabolic steroid" includes, but is not limited to, the following: 

(a) Boldenone; 

(b) Chlorotestosterone (4-chlortestosterone); 

(c) Clostebol; 

(d) Dehydrochlormethyltestosterone; 

(e) Dihydrotestosterone (4-dihydrotestosterone); 

(f) Drostanolone; 

(g) Ethylestrenol; 

(h) Fluoxymesterone; 

(i) Formebulone (formebolone); 

(j) Mesterolone; 

(k) Methandienone; 

(l) Methandranone; 

(m) Methandriol; 

(n) Methandrostenolone; 

(o) Methenolone; 

(p) Methyltestosterone; 

(q) Mibolerone; 

(r) Nandrolone; 

(s) Norethandrolone; 

(t) Oxandrolone; 

(u) Oxymesterone; 

(v) Oxymetholone; 

(w) Stanolone; 

(x) Stanozolol; 

(y) Testolactone; 

(z) Testosterone; 

(aa) Trenbolone; 

(bb) Any salt, ester, isomer, or salt of an ester or isomer of a drug or hormonal substance described or listed in division (E)(1) of schedule III if the salt, ester, or isomer promotes muscle growth. 

(F) Hallucinogenic substances 

(1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States food and drug administration approved drug product (some other names for dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-d ibenzo[b,d]pyran o-1-ol, or (-)-delta-9-(trans)-tetrahydrocannabinol). (7-2-99)2
   
SCHEDULE IV 

(A) Narcotic drugs 

Unless specifically excepted by federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below: (7-26-79) 

(1) Not more than one milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit; (9-27-78) 

(2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane)[final dosage forms]. (3-14-77) (7-24-80)2

(B) Depressants 

Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances, including their salts, isomers, and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: 

(1) Alprazolam; (11-12-81) 

(2) Barbital; (5-1-71) 

(3) Bromazepam; (11-5-84) 

(4) Camazepam; (11-5-84) 

(5) Chloral betaine; (5-1-71) 

(6) Chloral hydrate; (5-1-71) 

(7) Chlordiazepoxide; (7-2-75) [4-1-78] 

(8) Clobazam; (11-5-84) 

(9) Clonazepam; (7-2-75) [4-1-78] 

(10) Clorazepate; (7-2-75) [4-1-78] 

(11) Clotiazepam; (11-5-84) 

(12) Cloxazolam; (11-5-84) 

(13) Delorazepam; (11-5-84) 

(14) Diazepam; (7-2-75) [4-1-78] 

(15) Dichloralphenazone; (8-16-01) 

(16) Estazolam; (11-5-84) 

(17) Ethchlorvynol; (5-1-71) 

(18) Ethinamate; (5-1-71) 

(19) Ethyl loflazepate; (11-5-84) 

(20) Fludiazepam; (11-5-84) 

(21) Flunitrazepam; (11-5-84) 

(22) Flurazepam; (7-2-75) [4-1-78] 

(23) Halazepam; (10-29-81) 

(24) Haloxazolam; (11-5-84) 

(25) Ketazolam; (11-5-84) 

(26) Loprazolam; (11-5-84) 

(27) Lorazepam; (10-3-77) 

(28) Lormetazepam; (11-5-84) 

(29) Mebutamate; (1-30-75) 

(30) Medazepam; (11-5-84) 

(31) Meprobamate; (5-1-71) 

(32) Methohexital; (5-1-71) 

(33) Methylphenobarbital (mephobarbital); (5-1-71) 

(34) Midazolam; (3-25-86) 

(35) Nimetazepam; (11-5-84) 

(36) Nitrazepam; (11-5-84) 

(37) Nordiazepam; (11-5-84) 

(38) Oxazepam; (7-2-75) [4-1-78] 

(39) Oxazolam; (11-5-84) 

(40) Paraldehyde; (5-1-71) 

(41) Petrichloral; (5-1-71) 

(42) Phenobarbital; (5-1-71) 

(43) Pinazepam; (11-5-84) 

(44) Prazepam; (12-17-86) 

(45) Quazepam; (3-25-86) 

(46) Temazepam; (4-7-81) 

(47) Tetrazepam; (11-5-84) 

(48) Triazolam; (12-28-82) 

(49) Zaleplon; (9-15-99) 

(50) Zolpidem. (2-05-93) 

(C) Fenfluramine 

Any material, compound, mixture, or preparation that contains any quantity of the following substances, including their salts, their optical isomers, position isomers, or geometric isomers, and salts of these isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: 

(1) Fenfluramine. (6-15-73) 

(D) Stimulants 

Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, their optical isomers, position isomers, or geometric isomers, and salts of these isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: 

(1) Cathine ((+)-norpseudoephedrine); (6-16-88) 

(2) Diethylpropion; (9-1-73) 

(3) Fencamfamin; (6-16-88) 

(4) Fenproporex; (6-16-88) 

(5) Mazindol; (11-27-81) 

(6) Mefenorex; (6-16-88) 

(7) Modafinil; (1-27-81)2

(8) Pemoline (including organometallic complexes and chelates thereof); (1-28-75) 

(9) Phentermine; (9-1-73) 

(10) Pipradrol; (12-1-80) 

(11) Sibutramine; (2-11-98) 

(12) SPA [(-)-1-dimethylamino-1,2-diphenylethane]. (12-1-80) 

(E) Other substances 

Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances, including their salts: 

(1) Pentazocine; (2-9-79) 

(2) Butorphanol (including its optical isomers). (10-31-97) 
   
SCHEDULE V 

(A) Narcotic drugs 

Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any of the following narcotic drugs, and their salts, as set forth below: 

(1) [Reserved] (10-07-02)2

(B) Narcotics-narcotic preparations 

Narcotic drugs containing non-narcotic active medicinal ingredients. Any compound, mixture, or preparation that contains any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below, and that includes one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by narcotic drugs alone: (7-26-79) 

(1) Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams; (5-1-71) (6-20-74) 

(2) Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams; (5-1-71) (6-20-74) 

(3) Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams; (5-1-71) (6-20-74) 

(4) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit; (5-1-71) (6-20-74) 

(5) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams; (5-1-71) (6-20-74) 

(6) Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit. (9-27-78) 

(C) Stimulants 

Unless specifically exempted or excluded under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, isomers, and salts of isomers: 

(1) Ephedrine, except as provided in division (K) of section 3719.44 of the Revised Code;2

(2) Pyrovalerone. (5-4-88) 
 

HISTORY: 136 v H 300 (Eff 7-1-76); 144 v H 62 (Eff 5-21-91); 145 v H 156 (Eff 5-19-93); 145 v H 391 (Eff 7-21-94); 146 v S 269 (Eff 7-1-96); 148 v H 428. Eff 5-17-2000.
 

Å As enrolled in (C)(30) of the Revised Schedule of Controlled Substances by the State Board of Pharmacy (4-21-03). 

1 Levo-alphacetylmethadol was transferred to Schedule II by the Federal Government pursuant to Section 3719.43 of the Ohio Revised Code on August 18, 1993. 

2 Originally placed in Schedule I on 03/12/93 under the Temporary Scheduling provisions of the Federal Government. 

3 Originally placed in Schedule I on 01/06/94 under the Temporary Scheduling provisions of the Federal Government. 

4 Originally placed in Schedule I on 09/20/02 under the Temporary Scheduling provisions of the Federal Government. 

5 Originally placed in Schedule I on 04/04/03 under the Temporary Scheduling provisions of the Federal Government. 

6 Placed in Schedule II by the Board of Pharmacy pursuant to Section 3719.44 of the Revised Code on July 1, 1978. 

7 Placed in Schedule II by the Ohio Legislature pursuant to House Bill 428 to take effect May 17, 2000, but placement by the Federal Government into Schedule I takes precedence. [See Schedule III, paragraph (B)(5)] 

8 Methaqualone was previously placed by the Federal Government into Schedule II effective 10-04-73 and was moved, pursuant to Section 3719.43 of the Ohio Revised Code, to Schedule I effective 08-27-84. 

9 Originally placed in Schedule I on 09/21/92 under the Temporary Scheduling provisions of the Federal Government. 

10 Originally placed in Schedule I on 09/20/02 under the Temporary Scheduling provisions of the Federal Government. 

11 Originally placed in Schedule I on 05/01/92 under the Temporary Scheduling provisions of the Federal Government. 

12 Temporary scheduling is under federal law only. It is included here as a service and is not an actual part of Section 3719.41 of the Revised Code. All Schedule I restrictions and controls still apply to the substances listed until temporary placement expires or permanent placement occurs. Temporary placement will expire at the end of one year from the effective date but may be extended six months (noted by a second effective date). Emergency scheduling is intended to apply to "designer drugs". 

13 Both of the substances listed were under Schedule I restrictions for only a one-year period ending November 29, 1986. 

14 The substance listed was under Schedule I restrictions from 09/20/02 to 03/19/04. 

15 Alfentanil was previously placed by the Federal Government, pursuant to Section 3719.43 of the Ohio Revised Code, into Schedule I effective 08-24-84, and was moved to Schedule II effective 01-23-87. 

16 Dextropropoxyphene (final dosage forms) was reclassified in Schedule IV as a narcotic drug under federal drug abuse control laws on July 24, 1980. Bulk dextropropoxyphene (non-dosage forms) was placed in Schedule II on the same date. 

17 Levo-alphacetylmethadol was previously placed by the Federal Government, pursuant to Section 3719.43 of the Ohio Revised Code, into Schedule I effective 05-01-71, and was moved to Schedule II effective 08-18-93. 

18 Sufentanil was previously placed by the Federal Government, pursuant to Section 3719.43 of the Ohio Revised Code, into Schedule I effective 12-1-80, and was moved to Schedule II effective 5-25-84. 

19 Glutethimide was placed in Schedule III by the Federal Government on 05-01-71 and was moved to Schedule II by the Federal Government, pursuant to Section 3719.43 of the Ohio Revised Code, effective 03-21-91. 

20 (1-phenylcyclohexyl) ethylamine and 1-(1-phenylcyclohexyl) pyrrolidine were placed in Schedule II by the Board of Pharmacy on 07-01-78 and were moved to Schedule I by the Federal Government on 10-25-78. 

21 Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product was placed in Schedule II by the Federal Government on 05-13-86 and was moved to Schedule III by the Federal Government on 07-02-99. 

22 Xyrem (sodium oxybate) (07/17/02). [Also see Schedule I, paragraph (D)(1)] 

23 Buprenorphine was previously placed by the Federal Government, pursuant to Section 3719.43 of the Ohio Revised Code, into Schedule V effective 04/01/85, and was moved to Schedule III effective 10/07/02. 

24 Anabolic steroids was also added to Schedule III by the Ohio Legislature effective 05/21/91; a "cleanup" bill was passed by the Ohio Legislature on 05/19/93. 

25 Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product was placed in Schedule II by the Federal Government on 05-13-86 and was moved to Schedule III by the Federal Government on 07-02-99. 

26 Dextropropoxyphene (final dosage forms) was reclassified in Schedule IV as a narcotic drug under federal drug abuse control laws on 07-24-80. Bulk dextropropoxyphene (non-dosage forms) was placed in Schedule II on the same date. 

27 Mazindol was previously placed by the Federal Government into Schedule III effective 06-15-73 and was moved, pursuant to Section 3719.43 of the Ohio Revised Code, to Schedule IV effective 11-27-81. 

28 Buprenorphine was previously placed by the Federal Government into Schedule V effective 04/01/85 and was moved by the Federal Government to Schedule III effective 10/07/02. 

29 Ephedrine was added by the Ohio Legislature (Sub. H.B. 391) effective 07/21/94. 

Division (K) of Section 3719.44 of the Revised Code states: [effective 10/11/02] 

A drug product containing ephedrine that is known as one of the following and is in the form specified shall not be considered a schedule V controlled substance: 

(a) Amesec capsules; (effective 07/21/94) 

(b) Bronitin tablets; (effective 07/21/94) 

(c) Bronkotabs; (effective 07/21/94) 

(d) Bronkolixir; (effective 07/21/94) 

(e) Bronkaid tablets; (effective 07/21/94) 

(f) Efedron nasal jelly; (effective 07/21/94) 

(g) Guiaphed elixir; (effective 07/21/94) 

(h) Haysma; (effective 07/21/94) 

(i) Pazo hemorrhoid ointment and suppositories; (effective 07/21/94) 

(j) Primatene "M" formula tablets; (effective 07/21/94) 

(k) Primatene "P" formula tablets; (effective 07/21/94) 

(l) Tedrigen tablets; (effective 07/21/94) 

(m) Tedral tablets, suspension and elixir; (effective 07/21/94) 

(n) T.E.P.; (effective 07/21/94) 

(o) Vatronol nose drops. (effective 07/21/94) 

(2)(a) A product containing ephedrine shall not be considered a controlled substance if the product is a food product or dietary supplement that meets all of the following criteria: (effective 03/31/97) 

(i) It contains, per dosage unit or serving, not more than the lesser of twenty-five milligrams of ephedrine alkaloids or the maximum amount of ephedrine alkaloids provided in applicable regulations adopted by the United States food and drug administration, and no other controlled substance. 

(ii) It contains no hydrochloride or sulfate salts of ephedrine alkaloids. 

(iii) It is packaged with a prominent label securely affixed to each package that states all of the following: the amount in milligrams of ephedrine in a serving or dosage unit; the amount of the food product or dietary supplement that constitutes a serving or dosage unit; that the maximum recommended dosage of ephedrine for a healthy adult human is the lesser of one hundred milligrams in a twenty-four-hour period for not more than twelve weeks or the maximum recommended dosage or period of use provided in applicable regulations adopted by the United States food and drug administration; and that improper use of the product may be hazardous to a person's health. 

* * * 

(3) A drug product that contains the isomer pseudoephedrine, or any of its salts, optical isomers, or salts of optical isomers, shall not be considered a controlled substance if the drug product is labeled in a manner consistent with federal law or with the product's over-the-counter tentative final monograph or final monograph issued by the United States food and drug administration. (effective 03/31/97) 

(4) At the request of any person, the board may except any product containing ephedrine not described in division (K)(1) or (2) of this section or any class of products containing ephedrine from being included as a schedule V controlled substance if it determines that the product or class of products does not contain any other controlled substance. The board shall make the determination in accordance with this section and by rule adopted in accordance with Chapter 119. of the Revised Code. (effective 07/21/94 and 03/31/97) 

Board exceptions pursuant to Rule 4729-12-09 of the Administrative Code: 

(A) All products that contain the isomer known as pseudoephedrine or its salts, but do not also contain any of the isomer known as ephedrine or its salts. (excepted by emergency rule of the Board effective 08/24/94, and by permanent rule of the Board effective 12/15/94) 

(B) "Breathe Easy ®" herb tea. (exception effective 01/10/96) 

(C) "Bronkaid ® Dual Action" caplets. (exception effective 01/10/96) 

(D) "Hydrosal ®" hemorrhoidal ointment. (exception effective 01/10/96) 

(E) "Primatene ® Dual Action Formula" tablets. (exception effective 01/10/96) 

(F) "Primatene ®" tablets. (exception effective 01/10/96) 

(G) "SnoreStop TM" tablets. (exception effective 07/01/97) 

Division (L) of Section 3719.44 of the Revised Code states: [effective 10/11/02] 

"Food" means: [Sec. 3715.01 of the Ohio Revised Code effective 11/21/01] 

(1) articles used for food or drink for humans or animals. 

(2) chewing gum. 

(3) articles used for components of any such articles. 

"Dietary supplement": [21 USC 321(ff) of the United States Code effective 10/30/98] 

(1) means a product (other than tobacco) intended to supplement the diet that bears or contains one or more of the following dietary ingredients: (a) a vitamin; (b) a mineral; (c) an herb or other botanical; (d) an amino acid; (e) a dietary substance for use by man to supplement the diet by increasing the total dietary intake; or (f) a concentrate, metabolite, constituent, extract, or combination of any ingredient described in clause (a), (b), (c), (d), or (e); 

(2) means a product that (a) is intended for ingestion in a form described in section 350(c)(1)(B)(i) of this title; or complies with section 350(c)(1)(B)(ii) of this title; (b) is not represented for use as a conventional food or as a sole item of a meal or the diet; and (c) is labeled as a dietary supplement; and 

(3) does: 

(a) include an article that is approved as a new drug under section 355 of this title, certified as an antibiotic under section 357 of this title, or licensed as a biologic under section 262 of Title 42 and was, prior to such approval, certification, or license, marketed as a dietary supplement or as a food unless the Secretary has issued a regulation, after notice and comment, finding that the article, when used as or in a dietary supplement under the conditions of use and dosages set forth in the labeling for such dietary supplement, is unlawful under section 342(f) of this title; and 

(b) not include an article that is approved as a new drug under section 355 of this title, certified as an antibiotic under section 357 of this title, or licensed as a biologic under section 262 of Title 42, or an article authorized for investigation as a new drug, antibiotic, or biological for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public, which was not before such approval, certification, licensing, or authorization marketed as a dietary supplement or as a food unless the Secretary, in the Secretary's discretion, has issued a regulation, after notice and comment, finding that the article would be lawful under this chapter. 

"Ephedrine alkaloids" means: [Sec. 3719.44(L)(3) of the Ohio Revised Code effective 10/11/02] ephedrine, pseudoephedrine, norephedrine, norpseudoephedrine, methylephedrine, and methylpseudoephedrine. 
 

Not analogous to former RC § 3719.41 (132 v S 74), repealed 136 v H 300, eff 7-1-76.

The provisions of §§ 3, 9 of HB 156 (145 v  - ) read as follows: 

SECTION 3. (A) In amending section 3719.41 of the Revised Code in this act, it is the intent of the General Assembly to codify the following in controlled substances Schedules I to V: 

(1) The automatic addition of various compounds, mixtures, preparations, or substances to those schedules pursuant to section 3719.43 of the Revised Code following action taken by the United States Attorney General on or after July 1, 1976, and the addition of various compounds, mixtures, preparations, or substances to those schedules on or after July 1, 1976, by the State Board of Pharmacy pursuant to section 3719.44 of the Revised Code; 

(2) The automatic transfer of various compounds, mixtures, preparations, or substances within those schedules, and the automatic removal of various compounds, mixtures, preparations, or substances from those schedules, pursuant to section 3719.43 of the Revised Code following action taken by the United States Attorney General on or after July 1, 1976; 

(3) The transfer of various compounds, mixtures, preparations, or substances within those schedules, and the removal of various compounds, mixtures, preparations, or substances from those schedules on or after July 1, 1976, by the State Board of Pharmacy pursuant to section 3719.44 of the Revised Code. 

(B) The General Assembly hereby declares that, in amending section 3719.41 of the Revised Code in Am. Sub. H.B. 62 of the 119th General Assembly, it solely intended to legislatively add anabolic steroids to controlled substances Schedule III and did not intend to affect controlled substances Schedules I to V insofar as, prior to May 21, 1991, various compounds, mixtures, preparations, or substances had been added to, transferred within, or removed from those schedules pursuant to sections 3719.43 and 3719.44 of the Revised Code. 

SECTION 9. This act is hereby declared to be an emergency measure necessary for the immediate preservation of the public peace, health, and safety. The primary reason for the necessity is that the version of section 3719.41 of the Revised Code amended by Am. Sub. H.B. 62 of the 119th General Assembly and effective May 21, 1991, did not include certain compounds, mixtures, preparations, or substances that automatically had been added to controlled substances Schedules I to V pursuant to section 3719.43 of the Revised Code following action taken by the United States Attorney General on or after July 1, 1976, and did not reflect the automatic transfer of various compounds, mixtures, preparations, or substances within those schedules pursuant to section 3719.43 of the Revised Code following action taken by the United States Attorney General on or after July 1, 1976. The clarification of the status of controlled substances Schedules I to V is necessary to eliminate any uncertainty as to the nature of the controlled substances that may be the subject of offenses under Chapters 2925. and 3719. of the Revised Code. Therefore, this act shall go into immediate effect. 

Disclaimer: These codes may not be the most recent version. Ohio may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.